SnapShot: Ca2+-Calcineurin-NFATSignaling  by Crabtree, Gerald R. & Schreiber, Stuart L.
See online version for legend and references.
S
n
ap
S
h
o
t:
 C
a2
+
-C
al
ci
n
e
u
ri
n
-N
FA
T
 S
ig
n
al
in
g
G
er
al
d
 R
. C
ra
b
tr
ee
1  
an
d
 S
tu
ar
t 
L.
 S
ch
re
ib
er
2
1 S
ta
nf
o
rd
 U
ni
ve
rs
ity
 S
ch
o
o
l o
f 
M
ed
ic
in
e,
 S
ta
nf
o
rd
, C
A
 9
43
05
, U
S
A
; 2
B
ro
ad
 In
st
itu
te
 o
f 
H
ar
va
rd
 a
nd
 M
IT
, C
am
b
ri
d
g
e,
 M
A
 0
21
42
, U
S
A
210 Cell 138, July 10, 2009 ©2009 Elsevier Inc. DOI 10.1016/j.cell.2009.06.026
210.e1 Cell 138, July 10, 2009 ©2009 Elsevier Inc. DOI 10.1016/j.cell.2009.06.026
SnapShot: Ca2+-Calcineurin-NFAT  
Signaling
Gerald R. Crabtree1 and Stuart L. Schreiber2
1Stanford University School of Medicine, Stanford, CA 94305, USA; 2Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA
Ca2+-calcineurin-NFAT signaling transmits signals to the nucleus from a wide variety of receptors and is required for developmental events as diverse as axon out-
growth, cardiac morphogenesis, lung morphogenesis, neural crest diversification, epithelial stem cell maintenance, and immune responses. The pathway appears to be 
particularly dedicated to vertebrate-specific morphogenic events, perhaps reflecting its first evolutionary appearance in vertebrates. Calcineurin-NFAT signaling is the 
target of the drugs cyclosporin A and FK506 and several viral immune modulators. In addition, its malfunction is implicated in Down’s syndrome, diabetes, and cardiac 
hypertrophy.
Receptors that induce the entry of Ca2+ into the cell resulting in the activation of calcineurin phosphatase are shown in the lower left. Ca2+ binds to the regulatory 
subunit of calcineurin as well as to calmodulin to activate the phosphatase activity of calcineurin (Stemmer and Klee, 1994). The immunosuppressive drugs FK506 
and cyclosporin A inhibit calcineurin by binding first to the abundant intracellular proteins, FKBP and cyclophilin, respectively. These protein complexes then bind to 
calcineurin, preventing substrate access (Liu et al., 1991). The specificity of these calcineurin inhibitors is due to the large composite surface arising from FKBP bound 
to FK506 (see inset structure) (Griffith et al., 1995) or cyclosporin A bound to cyclophilin. FK506 and cyclosporin A are highly specific probes of the NFAT signaling path-
way in tissues where the concentration of calcineurin is less than the concentration of FKBP or cyclophilin (Graef et al., 2001). Calcineurin removes several phosphate 
residues from the N terminus of NFATc proteins, the Ca2+-calcineurin-sensitive subunits of NFAT transcription complexes. Removal of the phosphates exposes nuclear 
localization sequences in NFATc proteins leading to their rapid entry into the nucleus (Beals et al., 1997a). Once in the nucleus, the NFATc proteins assemble on DNA with 
partner proteins generically termed NFATn (lower right) that are often the endpoints of other signaling pathways (Crabtree and Olson, 2002). In most cases, NFAT-depen-
dent transcription requires that the Ca2+ signaling be coincident with MAP kinase signaling, providing a mechanism for signal integration and coincidence detection.
The targets of NFAT signaling (panel, upper right) are largely cytokines, growth factors and their receptors, proteins involved in cell-cell interactions, as well as many 
microRNAs. Of particular importance are positive feedback loops initiated by direct binding of NFATc1 and NFATc4 to their promoters as well as the regulation of Ca2+ 
channels, such as the IP3 receptor, responsible for the release of intracellular Ca2+ stores (Genazzani et al., 1999). This positive feedback loop appears to be important 
in committing cells to specific fates. A negative feedback loop mediated by the NFAT-dependent activation of RCAN (DSCR1) gene expression appears to constrain the 
pathway (Arron et al., 2006).
NFATc proteins are actively removed from the nucleus by first priming with Dyrk1a or protein kinase A (PKA) followed by phosphorylation by GSK3 (Arron et al., 2006; 
Beals et al., 1997b; Gwack et al., 2006). The inhibition of GSK3 by AKT and PI3 kinase (PI3K) signaling increases the level of NFATc proteins in the nucleus and hence 
provides a second means of coincidence detection and signal integration. Many of the phenotypes of Down’s syndrome are thought to be due to the duplication of the 
DSCR and Dyrk1a genes on chromosome 21. Increased gene dosage both reduces NFATc import into the nucleus and also facilitates export leading to a reduction in 
NFATc function and compromised positive feedback (Arron et al., 2006).
Abbreviations
AKT, the cellular homolog of the acute transforming oncogene v-AKT; BCR, B cell receptor; CRAC, Ca2+ release-activated Ca2+ channel; DSCR1/RCAN, Down’s syn-
drome critical region 1, now called regulator of calcineurin; Dyrk1a, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A; FKBP, FK506-binding protein; 
GSK3, glycogen synthease kinase 3; IP3R1, inositol 1,4,5-triphosphate receptor 1; NFAT, nuclear factor of activated T cells; NMDA, N-methyl-D-aspartate recep-
tor; NFATc, Ca2+-calcineurin-dependent subunits of NFAT complexes, also cyclosporin-sensitive subunit of NFAT complexes; NFATn, generic name for nuclear sub-
units of NFAT-transcription complexes; NF-κB, nuclear factor binding to the immunoglobulin kappa locus in B cells; PI3K, phosphatidylinositol 3-kinase; IP3, inositol 
1,4,5-triphosphate; PLCγ, phospholipase gamma; STIM, stromal interaction molecule; Sox2, sex determination-box containing gene; TRP, transient receptor potential 
channel; TCR, T cell receptor; VEGF, vascular endothelial growth factor
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